GLYPRESSIN is a brand name for Terlipressin. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: Glypressin® is indicated in the treatment of bleeding oesophageal varices.
Verbatim from this product's MHRA label. Tap a section to expand.
v. injection of 2 mg Glypressin is given every 4 hours. The treatment should be maintained until bleeding has been controlled for 24 hours, but up to a maximum of 48 hours. v. every 4 hours in patients with body weight < 50 kg or if adverse effects occur.
Paediatric population:
There is no relevant use of Glypressin in paediatric population. Method of administration Intravenous injection use
Summary of safety profile The most frequently reported undesirable effects in clinical trials are abdominal pain, nausea, diarrhoea, pallor, vomiting, and bradycardia. 4 for further information Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important.
It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard.
Monitoring during treatment During treatment regular monitoring of blood pressure, ECG or heart rate, oxygen saturation, serum levels of sodium and potassium, as well as fluid balance are required. Particular care is required in the management of patients with cardiovascular or pulmonary disease since terlipressin may induce ischaemia and pulmonary vascular congestion.
Caution should also be exercised in treating patients with hypertension. v. Septic shock In patients with septic shock with a low cardiac output Glypressin should not be used. 8). Patients with diabetes mellitus and obesity seem to have a greater tendency to this reaction.
Therefore, caution should be exercised when administering terlipressin in these patients. 8). In most cases, patients had predisposing factors such as basal prolongation of the QT interval, electrolyte abnormalities (hypokalemia, hypomagnesemia) or medications with concomitant effect on QT prolongation.
5).
Children and the elderly:
Particular caution should be exercised in the treatment of children and elderly patients, as experience is limited in these groups. There is no data available regarding dosage recommendation in these special patient categories.
Contraindicated in pregnancy. 1.
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Terlipressin in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.